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The a2HS glycoprotein receptor form lymphocytes transformed by Epstein-Barr Virus was isolated by 
affinity chromatography. The protein receptor has a monomer M, of 48 000, which is similar to the 
Epstein-Barr virus-determined nuclear antigen (EBNA), and p1 = 7.2. Like EBNA the 48 000 Mr compo- 
nent in unfractionated labelled detergent solubilised cell supernatants also binds DNA. These results may 
suggest some similarity between the a2HS receptor and EBNA. 
a2HS glycoprotein Epstein-Barr virus 
1. INTRODUCTION 
Epstein-Barr Virus (EBV) infects B lymphocytes 
leading to immortalization of the cell line [ 11. Cells 
transformed by EBV synthesize and express se- 
quential sets of virally-determined antigens. The 
initial expression of the EBV-determined nuclear 
antigen (EBNA) is closely followed by the virus- 
induced, lymphocyte-detected membrane antigen 
(LYDMA) 121. Expression of other viral-deter- 
mined antigens is tightly controlled and dependent 
on the induction of a productive or lytic cycle which 
leads to the synthesis of early antigen (EA), viral 
capsid antigen (VCA), and late membrane antigen 
(LMA) [I]. Isolation and characterization of 
EBV-determined antigens is important for under- 
standing the control of EBV infection and attention 
has been focused on EBNA and LYDMA which are 
expressed in non-productive infection [ 11, and may 
play a role in immune defense mechanisms against 
EBV infection 131. 
We had supposed that the serum protein a2HS 
glycoprotein (“2HS) could fullil criteria as a 
mediator enhancing host defense mechanisms against 
EBV-transformed cells, as it binds to lymphocytes 
transformed by EBV [4], promotes macrophage 
phagocytic function [5,6] and acts as an opsonin 
during bacterial phagocytosis by human neutro- 
phils 171. The ability of a2HS to bind to lymphocytes 
Virus transformation Glycoprotein receptor 
transformed by EBV, but not to normal autologous 
non-transformed lymphocytes 141, therefore 
necessitates the isolation and characterization of the 
(Y~HS receptor. 
Here we report the isolation of the a2HS receptor 
from labelled detergent solubilized EBV-trans- 
formed lymphocyte supernatants by affinity chroma- 
tography. The protein receptor has a monomeric Mr 
of 48 000, which is similar to EBNA, and pI = 7.2. 
Like EBNA, the 48 000 Mr component in unfrac- 
tionated, labelled detergent solubilized cell super- 
natants also binds to DNA. These results may sug- 
gest some relationship between the a2HS receptor 
and EBNA. 
2. MATERIALS AND METHODS 
Peripheral blood lymphocytes were transformed 
with EBV culture supernatants derived from the 
B95-8 cell line [8]. The mycoplasma and bacteria 
free cell line was cultured as in [4]. Transformed 
cells (- 10’) were washed 3 x with phosphate-buf- 
fered saline (PBS) and 1251-labelled by the peroxid- 
ase method [9]. The labelled cells were deter- 
gent-solubilized with 1 .O ml borate-buffered saline 
(BBS) (pH 8.5) containing 1% NP40 and 2 mM 
phenylmethylsulphonyl fluoride (PMSF) and the 
30 000 x g supernatant incubated with 1.0 ml 
olzHS-Sepharose 4B (2.5 mg azHS/ml Sepharose 
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4B) overnight at 4°C. Unbound material was re- acetic acid, stained, destained and prepared for 
moved by washing the column with 100 ml BBS autoradiography by drying onto Whatman 3MM 
containing 1% NP40. Bound material was eluted at paper. M,-Markers were phosphorylase B (97 000) 
4°C with 0.5 M acetic acid containing 1% NP40. bovine serum albumin (68 000) ovalbumin 
Following dialysis the bound fraction was concen- (44 000) carbonic anhydrase (29 000) and lyso- 
trated by ultrafiltration. Purified (u~HS receptor and zyme (14 000). ‘251-alAT (52000) was used as a 
labelled, unfractionated, detergent-solubilized cell marker for autoradiography. Samples were incu- 
supernatant (10 p.I) were also subjected to pronase bated with 2% SDS, 95°C for 5 min, prior to 
or RNase digestion (2 mg/ml in PBS containing 2 electrophoresis, usually in the presence of mer- 
mM MgClz) for 60 min at 22°C. captoethanol. 
Gel filtration was carried out in a 2.5 x 90 cm 
column using Aca 34. Fractions, 30 min, were col- 
lected at 27 ml/h. Columns were run in BBS con- 
taining 1% NP40. ‘251-alAT and ‘251-CEA were 
used as M,-markers. Fractions were counted to de- 
termine elution profiles. 
Isoelectric focusing was carried out in 4% poly- 
acrylamide disc gels in the presence of 8 M urea and 
4% ampholine solution, pH 3- 10 (Sigma). 
DNA-agarose affinity chromatography was 
carried out on the a2HS receptor and labelled un- 
fractionated detergent solubilized cell supernatants 
in 10 mM phosphate buffer (pH 6.6). Following 
binding, 4 h at 22”C, the bound fraction was eluted 
with 10 mM phosphate buffer (pH 6.6) containing 
0.5 M NaCl and concentrated by ultrafiltration. 
Samples were loaded at the cathode and haemo- 
globin used to monitor focusing. At completion 
gels were sliced into 2 mm segments and placed in 
tubes along with 0.5 ml deionised distilled water for 
elution. Gel slices were counted and the pH of the 
eluted fractions determined. 
3. RESULTS 
SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) was carried out according to Laemmli 
[lo] in 5-20% gradient slab gels. Following 
electrophoresis gels were fixed in 10% trichloro- 
The isolation procedure resulted in the elution of 
-O.Ol-0.1% of the radioactivity applied to the 
cy*HS-Sepharose 4B column. The bound radio- 
activity was routinely eluted with 0.5 M acetic acid 
containing 1% NP40 which was equally effective as 
competitive elution with (Y~HS solution (2 ml-2.0 
mg/ml in PBS with 1% NP40) (fig.1). Following 
dialysis the acid-eluted receptor suffered an 80% 
loss in rebinding to the affinity column and did not 
bind to DNA-agarose. Gel filtration of the 
1251-(u2HS receptor along with ‘251-(wtAT is shown 
in fig.2. The ‘251-a2HS receptor like ‘251-CEA 
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Fig.1. Affinity purification of receptor on azHS-Sephar- 
ose4B. The column was washed with BBS containing 1% 
NP40 and the bound fraction eluted, (T). Elution profile 
is shown using qHS solution (-) or 
acetic acid (---). 
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Fig.2. Aca 34 gel filtration of a2HS receptor (-) and 
tZ51-cytAT (---)_ The void and column volumes are indi- 
cated as VO and V,. respectively. 
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(200000 Mr) eluted at the void volume (V,), 
‘251-CEA elution profile is not shown. Isoelectric 
focusing of the qHS receptor revealed a 
pI = 7.2 20.1 (n = 3) with some material barely 
penetrating the polyacrylamide gel (fig.3). SDS- 
PAGE results are shown in fig.4. Autoradiographs 
of the qHS receptor revealed a monomer M, = 
48 000 in both the presence and absence of mer- 
captoethanol. An aggregated form showed at the 
origin. The 48 000 M, band was also present in 
labelled, unfractionated, detergent-solubilized cell 
supernatants in both the presence and absence of 
mercaptoethanol. An autoradiograph of RNase- 
treated, labelled, unfractionated, detergent-solubil- 
ized cell supernatants is also shown. Pronase treat- 
ment of the qHS receptor and labelled, unfraction- 
ated, detergent-solubilized cell supernatants 
abluted all autoradiographic bands whereas treat- 
ment with RNase did not. Autoradiographs of the 
labelled, unfractionated, detergent-solubilized cell 
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Fig.3. Isoelectric focusing of a2HS receptor in 4% poly- 
acrylamide gels. Following focusing gels were sliced and 
counted (-). The pH gradient is also indicated (O-O). 
The isolectric point is shown (w) (PI = 7.2). 
Figd. Autoradiograph of 1251-labelled proteins analyzed by SDS-PAGE. Labelled unfractionated detergent solubilized 
EBV-transformed lymphocyte supernatants without mercaptoethanol (a); with mercaptoethanol (b,e); with mercapto- 
ethanol after RNase treatment (f). a2HS receptor in the presence and absence of mercaptoethanol, (c) and (d), respecti- 
vely. t2katAT is shown, (g); as are protein standards stained with Coomassie blue (h). The 48 000 M, receptor band is 
indicated. 
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F&S. Autoradiograph of labelled, detergent-solubilized 
cell supematant DNA-binding proteins from EBV- 
transformed lymphocytes. tZ51-atAT (a, e); labelled, 
unfractionated, detergent-solubilized cell supernatant 
proteins reduced with mercaptoethanol (b); DNA- 
agarose bound proteins in the presence and absence of 
mercaptoethanol (c) and (d), respectively. Proteins not 
retained by DNA-agarose incubated with mercapto- 
ethanol (f). The 48 000 M, band is shown. 
supernatant and the DNA-binding fraction are 
shown in fig.5. The 48 000 M, band was present in 
both the unfractionated and the DNA-binding 
samples, again under both reducing and non- 
reducing conditions. 
4. DISCUSSION ACKNOWLEDGEMENTS 
Transformation of B lymphocytes with B95-8 
supematants results in non-productive infection and 
as such EA, VCA and LMA would not be expected 
to be expressed [l]. Kutner and Sugden have 
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Crosier for transforming the cells. 
detected a unique antigen on the cell surface during 
non-productive infection of 45 000 M, which may 
correspond to LYDMA [ 1 I]. Like LYDMA, EBNA 
which is also expressed in non-productive infection 
has received much attention as it is considered to be 
an EBV-transforming protein [12], EBNA binds to 
DNA [13] and M, determinations vary from a 
tetramer with a monomeric M, = 48 000 [13,14]; 
50 000 M, [ 151; 65 000 Mr [ 161 to a complex consis- 
ting of a 100000, 50000 and a 70 000 M, heat- 
labile component [ 171. This variation in M, thought 
to reflect multiple antigenic determinants in EBNA 
[ 161. The monomer M, of the a2HS receptor and its 
existence as an SDS dissociable, aggregate form is 
in agreement with that of EBNA [ 13,141 although its 
apparent inability to bind DNA may preclude it 
being this antigen. However, our acid elution tech- 
nique could conceivably cause loss of this property 
as an 80% loss in rebinding to cyzHS--Sepharose 4B 
occurred. It was not possible to test whether the 
a2HS receptor with (u~HS solution bound to 
DNA-agarose as their similar Mr-values would 
have made separation difficult. Complete separa- 
tion would have to be achieved as (u~HS itself binds 
to DNA [18]. The basic p1 of the a2HS receptor, 
p1 = 7.2, makes it a likely candidate for binding to 
DNA on the basis of charge alone. DNA-agarose 
affinity chromatography of the labelled, unfraction- 
ated, detergent-solubilized cell supernatant re- 
vealed a 48 000 M, DNA-binding protein. The 
identical M, of this DNA-binding protein to the 
(u~HS receptor and their identical migration under 
both reducing and non-reducing conditions strongly 
suggests they are the same protein. As the a2HS 
receptor is identical in size to the M, of EBNA 
reported in [ 131 and it appears that like EBNA, the 
a2HS receptor binds DNA, some relationship be- 
tween the (u~HS receptor and EBNA is suggested. 
The exact relationship of the a2HS receptor to 
EBNA should be clarified by the production of 
specific antibody to the a2HS receptor and immuno- 
logical comparison with precipitates produced by 
anti-EBNA serum. 
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